Quick Answer
Privia Health Group, Inc. reported Cash And Cash Equivalents At Carrying Value of $479.69 million for the year ending 2025.
- Privia Health Group, Inc. showed a decrease of -2.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Privia Health Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $81.94 million | Q2 2021: $299.75 million | Q3 2021: $362.11 million | Q1 2022: $315.93 million | Q2 2022: $292.19 million | Q3 2022: $316.90 million | Q1 2023: $311.23 million | Q2 2023: $317.95 million | Q3 2023: $330.39 million | Q1 2024: $351.14 million | Q2 2024: $387.35 million | Q3 2024: $422.00 million | Q1 2025: $469.33 million | Q2 2025: $390.13 million | Q3 2025: $441.35 million.
- Over the full 6 years of available data (2020 to 2025), Privia Health Group, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 466.8%.
- Historical annual values: Fiscal year 2025: $479.69 million | Fiscal year 2024: $491.15 million | Fiscal year 2023: $389.51 million | Fiscal year 2022: $347.99 million | Fiscal year 2021: $320.58 million | Fiscal year 2020: $84.63 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: